Novel triple‑positive markers identified in human non‑small cell lung cancer cell line with chemotherapy-resistant and putative cancer stem cell characteristics
Novel triple‑positive markers identified in human non‑small cell lung cancer cell line with chemotherapy-resistant and putative cancer stem cell characteristics
Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis: Cell
Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer | Cell Death & Disease
Blockade of Notch3 inhibits the stem-like property and is associated with ALDH1A1 and CD44 via autophagy in non-small lung cancer
Processes | Free Full-Text | Cancer Stem Cell Microenvironment Models with Biomaterial Scaffolds In Vitro | HTML
Targeting cancer stem cell pathways for cancer therapy | Signal Transduction and Targeted Therapy
Frontiers | Targeting Lung Cancer Stem Cells: Research and Clinical Impacts | Oncology
Targeting cancer stem cell pathways for cancer therapy | Signal Transduction and Targeted Therapy
Targeting cancer stem cell pathways for cancer therapy | Signal Transduction and Targeted Therapy
Lung Cancer Stem Cells and Cancer Stem Cell-targeting Natural Compounds | Anticancer Research
The key roles of cancer stem cell-derived extracellular vesicles | Signal Transduction and Targeted Therapy
Targeting cancer stem cell pathways for cancer therapy | Signal Transduction and Targeted Therapy
Lung cancer stem cells—characteristics, phenotype - Hardavella - Translational Lung Cancer Research
PDF) Cancer stem cells: Progress and challenges in lung cancer
Novel triple‑positive markers identified in human non‑small cell lung cancer cell line with chemotherapy-resistant and putative cancer stem cell characteristics
Cancer stem cell impact on clinical oncology
A unique small cell lung carcinoma disease progression model shows progressive accumulation of cancer stem cell properties and CD44 as a potential diagnostic marker - Lung Cancer
Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance | Clinical Epigenetics | Full Text
Cancers | Free Full-Text | Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells | HTML
Systematic Identification of Molecular Subtype-Selective Vulnerabilities in Non-Small-Cell Lung Cancer: Cell
Lung Cancer Stem Cell: New Insights on Experimental Models and Preclinical Data
Frontiers | Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies | Immunology
